Followers | 523 |
Posts | 6631 |
Boards Moderated | 1 |
Alias Born | 07/24/2012 |
![](https://investorshub.advfn.com/uicon/352842.png?cb=1710834354)
Sunday, October 07, 2012 6:05:16 PM
Amarantus is on the verge of delivering startling new breakthroughs in the diagnosis and treatment of neurological disorders from Parkinson's disease to Traumatic Brain Injury (TBI). Amarantus owns the rights to a promising therapeutic protein known as MANF that prevents a type of cell death called apoptosis as well as the license to a groundbreaking diagnostic platform called NuroPro that allows neurologists to accurately diagnose and track the progression of Parkinson's disease in patients.
http://www.marketwatch.com/story/rbcc-extends-joint-venture-negotiations-with-amarantus-2012-07-25
FEATURED Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • Sep 4, 2024 9:02 AM
FEATURED Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • Sep 4, 2024 8:45 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM